Literature DB >> 3403822

Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrhythmia.

E A Raeder1, S H Hohnloser, T B Graboys, P J Podrid, S Lampert, B Lown.   

Abstract

Day to day variability of ventricular ectopic activity was analyzed in 45 patients with a history of malignant ventricular tachyarrhythmias who underwent two successive 24 h periods of ambulatory electrocardiographic (ECG) monitoring in the absence of antiarrhythmic drugs; 26 were male and 19 female, with a mean age of 56 years (range 15 to 76). The total number of single ventricular premature beats, couplets and ventricular tachycardia beats and runs on days 1 and 2 demonstrated a consistent overall correlation (r = 0.76 to 0.84). Individual variability was evaluated by regression analysis with determination of 95% confidence limits. The minimal decrease in arrhythmia density necessary to distinguish true drug effect from spontaneous variability was 64% for single ventricular premature beats, 83% for couplets, 90% for ventricular tachycardia runs and 93% for ventricular tachycardia beats. To meet the criteria for arrhythmia aggravation, the arrhythmia density had to increase by 400, 877, 1,500 and 2,400%, respectively. Multivariate analysis disclosed an inverse relation between day to day arrhythmia variability and baseline arrhythmia density and age. Variability was more pronounced in patients with coronary artery disease but was not influenced by the type of presenting arrhythmia or left ventricular function. The diurnal distribution of arrhythmias and heart rate followed a distinct circadian pattern. These data indicate that, despite good group reproducibility, spontaneous arrhythmia variability in individuals is substantial, necessitating standards to define both drug effect and arrhythmia aggravation.

Entities:  

Mesh:

Year:  1988        PMID: 3403822     DOI: 10.1016/s0735-1097(88)80052-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

Review 1.  Chronotherapeutics for cardiovascular disease.

Authors:  Y A Anwar; W B White
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

2.  Repeatability of ectopic beats from 48-hr ambulatory electrocardiography: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Michelle L Meyer; Elsayed Z Soliman; Lisa M Wruck; Thomas H Mosley; Lynne E Wagenknecht; Anna K Poon; Eric A Whitsel; Alvaro Alonso; Gerardo Heiss; Laura R Loehr
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-01-06       Impact factor: 1.468

Review 3.  Treatment Or Cure Of Right Ventricular Outflow Tract Tachycardia.

Authors:  Abdel J Fuenmayor
Journal:  J Atr Fibrillation       Date:  2014-06-30

Review 4.  Efficacy of aldosterone receptor antagonism in heart failure: potential mechanisms.

Authors:  Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2004-07

5.  Morning surge of ventricular arrhythmias in a new arrhythmogenic canine model of chronic heart failure is associated with attenuation of time-of-day dependence of heart rate and autonomic adaptation, and reduced cardiac chaos.

Authors:  Yujie Zhu; Mohamed A Hanafy; Cheryl R Killingsworth; Gregory P Walcott; Martin E Young; Steven M Pogwizd
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.